Unidade Acadêmica Ciências da Saúde, Universidade Federal de Jataí, Jataí, Goiás, Brazil.
Departamento de Bioquímica e Imunologia, Faculdade de Medicina de Ribeirão Preto, USP, Ribeirão Prêto, São Paulo, Brazil.
World J Microbiol Biotechnol. 2022 Jan 12;38(3):39. doi: 10.1007/s11274-022-03227-2.
The emergence of multidrug-resistant bacteria, viruses and tumors is a serious threat to public health. Among natural peptides, indolicidin, a 13-residue peptide belonging to the cathelicidin family, deserves special attention. Indolicidin has a broad spectrum of biological activity and is active against a wide range of targets, such as bacteria (Gram+ and Gram-), fungi and viruses. Here, we review the most important features of the biological activity, potential applications and perspectives of indolicidin and its analogs. Although not yet approved for commercialization, this peptide has great potential to be applied in different areas, including the medical, biomedical, food industry and other unexplored areas. To achieve this goal, a multidisciplinary team of researchers must work together to fine tune peptides that overall lead to novel analogs and formulations to combat existing and possibly future diseases.
耐药细菌、病毒和肿瘤的出现对公众健康构成了严重威胁。在天然肽中,属于抗菌肽家族的 13 个氨基酸的抑菌肽值得特别关注。抑菌肽具有广谱的生物活性,对广泛的靶标具有活性,如细菌(革兰氏阳性菌和革兰氏阴性菌)、真菌和病毒。在这里,我们回顾了抑菌肽及其类似物的生物活性、潜在应用和前景的最重要特征。尽管尚未获得商业化批准,但这种肽具有很大的应用潜力,可以应用于不同领域,包括医疗、生物医学、食品工业和其他尚未开发的领域。为了实现这一目标,一个多学科的研究团队必须共同努力,对肽进行微调,从而产生新的类似物和配方,以应对现有和可能出现的疾病。